Novartis plans Zolgensma giveaways as some fear 'health lottery'

Novartis aims to give away 100 doses of its $2.1 million-per-patient Zolgensma for spinal muscular atrophy (SMA) in 2020 in a free-drug program that one patient group worried was a "health lottery" that could neglect some babies.

from Reuters: Health News https://ift.tt/34yFGLy